INSELMA - a Randomised Controlled Trial | MicrobiomeTrials← Back to trialsNCT06583980
INSELMA - a Randomised Controlled Trial
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-09-05Est. Completion: 2027-08-31
Enrollment target: 120 participants Locations- Frederiksberg Hospital, Frederiksberg, Denmark
- Rigshospitalet-Glostrup, Glostrup Municipality, Denmark
- Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark
Other microbiome trials you might be interested in
Rare DiseasesGeneralized Myasthenia Gravis (gMG)
This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describ…
Kazan', RussiaEst. completion Dec 31, 2029
Rhematoid Arthritis
Rheumatoid arthritis is a chronic, systemic, autoimmune inflammatory disease that mainly affects the joints and periarti…
Sohag, EgyptEst. completion Jan 1, 2027